United States:
The United States cancer biomarker market is highly advanced, driven by substantial investments in research and development, a well-established healthcare system, and a focus on early diagnosis and personalized medicine. The prevalence of various types of cancer and strong governmental support for cancer research contribute significantly to market growth. The U.S....
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian